Litcius/Paper detail

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Fenella J. Kirkham, Stéphane Auvin, Joana Moreira, Helena Gama, Amílcar Falcão, José‐Francisco Rocha, Patrício Soares‐da‐Silva

2020Epilepsy & Behavior25 citationsDOIOpen Access PDF

Topics & Concepts

Refractory (planetary science)MedicinePlaceboDouble blindEpilepsyPediatricsClinical trialRandomized controlled trialAnesthesiaInternal medicinePsychiatryPhysicsPathologyAstrobiologyAlternative medicineEpilepsy research and treatmentNeuroscience and Neuropharmacology ResearchEEG and Brain-Computer Interfaces
Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial | Litcius